Kalvista Pharmaceuticals (KALV) Q3 2025 Earnings

Jul 10Confirmed
Q3 2024
Q4 2024
Q1 2025
Q3 2025
-0.99
-0.93
-0.86
-0.8

Details

Expected EPS
-0.798889
Actual EPS
-0.99
Surprise EPS
-0.19
Surprise Percent
-23.92%

Description

⁨Kalvista Pharmaceuticals⁩ (⁦KALV⁩) has reported earnings of ⁦-0.99⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts